Maximilian Trum

6PUBLICATIONS
32CO-AUTHORS
Respiratory diseasesMolecular targetsCardiology (incl. cardiovascular diseases)PharmacogenomicsNanoelectromechanical systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 10, 2024
Empagliflozin inhibits increased Na influx in atrial cardiomyocytes of patients with HFpEF.

Maximilian Trum, Johannes Riechel, Elisa Schollmeier

|Oct 17, 2022
Empagliflozin Inhibits Cardiac Late Sodium Current by Ca/Calmodulin-Dependent Kinase II.

Julian Mustroph, Maria J Baier, Steffen Pabel

|Sep 29, 2021
Enhanced Heart Failure in Redox-Dead Cys17Ser PKARIα Knock-In Mice.

M M Towhidul Islam, Daniel Tarnowski, Min Zhang

|Oct 09, 2020
Inhibition of cardiac potassium currents by oxidation-activated protein kinase A contributes to early afterdepolarizations in the heart.

M Trum, M M T Islam, S Lebek

|Sep 18, 2020
Empagliflozin inhibits Na+ /H+ exchanger activity in human atrial cardiomyocytes.

Maximilian Trum, Johannes Riechel, Simon Lebek

|Jun 23, 2020
NCX1 represents an ionic Na+ sensing mechanism in macrophages.

Patrick Neubert, Arne Homann, David Wendelborn

Pageof 1

Frequent Collaborators

4 joint publications

Stefan Wagner

3 joint publications

Lars S Maier

2 joint publications

Zdenek Provaznik

1 joint publications

Nazha Hamdani